As the United States heads into the colder weather months, cases of respiratory syncytial virus (RSV) have been ticking up across the country. For the week ending Nov. 25, there were 8,863 positive ...

Respiratory syncytial virus (RSV) is a common virus that affects the throat, nose, and lungs. Symptoms include a runny nose, congestion, sneezing, wheezing, cough, and fever, and these are often mild ...

NEW YORK CITY -- In September, an 8-month-old baby came into Dr. Juanita Mora's office in Chicago with an infection the doctor hadn't expected to see for another two months: RSV. Like her peers across ...

Add Yahoo as a preferred source to see more of our stories on Google. Respiratory Syncytial Virus or RSV is one of the most common respiratory viruses circulating today. Often thought of as only being ...

Respiratory infections are the leading causes of hospitalizations, ED visits and mortality in children in the United States ...

Beyfortus is not a vaccine. It’s a monoclonal antibody designed to help protect babies from serious RSV lung infection during ...

Respiratory syncytial virus (RSV) is spreading across the country, but it’s not too late to take steps to protect babies from ...

Antibodies harvested from the blood of paediatricians are up to 25 times better at protecting against the common respiratory ...

This week in JAMA Network Open, a team led by researchers from respiratory syncytial virus (RSV) vaccine-maker Pfizer ...

Nirsevimab is a long-acting monoclonal antibody that provides season-long protection against RSV in infants, reducing medically attended infections and hospitalizations. Maternal vaccination and ...